{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:41:11Z","timestamp":1793767271957,"version":"4.6.1"},"reference-count":20,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"unspecified","delay-in-days":27,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Surg Interv Health Technologies"],"accepted":{"date-parts":[[2023,8,22]]},"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1136\/bmjsit-2023-000186","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:20:27Z","timestamp":1695946827000},"page":"e000186","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":12,"title":["Medical device risk (re)classification: lessons from the FDA\u2019s 515 Program Initiative"],"prefix":"10.1136","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9347-494X","authenticated-orcid":false,"given":"Maryam","family":"Mooghali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9763-9075","authenticated-orcid":false,"given":"Vinay K","family":"Rathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kushal T","family":"Kadakia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9218-3320","authenticated-orcid":false,"given":"Joseph S","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0674-2032","authenticated-orcid":false,"given":"Sanket S","family":"Dhruva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,9,28]]},"reference":[{"key":"2024051514373634000_5.1.e000186.1","unstructured":"U.S. Food and Drug Adminstration . Regulatory controls. 2018. Available: https:\/\/www.fda.gov\/medical-devices\/overview-device-regulation\/regulatory-controls [Accessed 26 Jan 2023]."},{"key":"2024051514373634000_5.1.e000186.2","unstructured":"Institute of Medicine . Medical Devices and the Public\u2019s Health: The FDA 510(k) Clearance Process at 35 Years. Washington, DC: The National Academies Press, 2011."},{"key":"2024051514373634000_5.1.e000186.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.8761"},{"key":"2024051514373634000_5.1.e000186.4","unstructured":"U.S. Food and Drug Adminstration . Reclassification. 2021. Available: https:\/\/www.fda.gov\/about-fda\/cdrh-transparency\/reclassification [Accessed 26 Jan 2023]."},{"key":"2024051514373634000_5.1.e000186.5","unstructured":"U.S. Food and Drug Administration . Making permanent regulatory flexibilities provided during the COVID-19 public health emergency by exempting certain medical devices from premarket notification requirements; withdrawal of proposed exemptions: Federal register. 2021. Available: https:\/\/www.federalregister.gov\/documents\/2021\/04\/16\/2021-07760\/making-permanent-regulatory-flexibilities-provided-during-the-covid-19-public-health-emergency-by [Accessed 26 Jan 2023]."},{"key":"2024051514373634000_5.1.e000186.6","doi-asserted-by":"crossref","unstructured":"Rogers P . Regulating the innovators: approval costs and innovation in medical technologies. SocArXiv [Preprint] 2022. doi:10.31235\/osf.io\/c8s3m","DOI":"10.31235\/osf.io\/c8s3m"},{"key":"2024051514373634000_5.1.e000186.7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/jamacardio.2016.0002","article-title":"The US Food and Drug Administration 515 Program Initiative: addressing the evidence gap for widely used, high-risk cardiovascular devices?","volume":"1","author":"Rathi","year":"2016","journal-title":"JAMA Cardiol"},{"key":"2024051514373634000_5.1.e000186.8","unstructured":"U.S. Food and Drug Administration . 515 Program Initiative. 2017. Available: https:\/\/www.fda.gov\/about-fda\/cdrh-transparency\/515-program-initiative [Accessed 26 Jan 2023]."},{"key":"2024051514373634000_5.1.e000186.9","unstructured":"U.S. Food and Drug Adminstration . Effective date of requirement for premarket approval for total metal-on-metal semi-constrained hip joint systems. 2016. Available: https:\/\/www.govinfo.gov\/content\/pkg\/FR-2016-02-18\/pdf\/2016-03331.pdf [Accessed 26 Jan 2023]."},{"key":"2024051514373634000_5.1.e000186.10","unstructured":"U.S. Food and Drug Administration . Recalls background and definitions. 2014. Available: https:\/\/www.fda.gov\/safety\/industry-guidance-recalls\/recalls-background-and-definitions#:~:text=Class%20I%20recall%3A%20a%20situation,adverse%20health%20consequences%20or%20death [Accessed 26 Jan 2023]."},{"key":"2024051514373634000_5.1.e000186.11","unstructured":"U.S. Food and Drug Adminstration . Premarket approval for automated external defibrillator systems; Republication. 2015. Available: https:\/\/www.govinfo.gov\/content\/pkg\/FR-2015-02-03\/pdf\/2015-02049.pdf [Accessed 26 Jan 2023]."},{"key":"2024051514373634000_5.1.e000186.12","unstructured":"U.S. Food and Drug Adminstration . Reclassification of membrane lung for long-term pulmonary support; Redesignation as extracorporeal circuit and accessories for long-term respiratory\/cardiopulmonary failure. 2016. Available: https:\/\/www.govinfo.gov\/content\/pkg\/FR-2016-02-12\/pdf\/2016-02876.pdf [Accessed 26 Jan 2023]."},{"key":"2024051514373634000_5.1.e000186.13","unstructured":"U.S. Food and Drug Adminstration . Cardiovascular devices; reclassification of nonroller-type cardiopulmonary bypass blood pumps for cardiopulmonary and circulatory bypass; effective date of requirement for premarket approval for nonroller-type cardiopulmonary bypass blood pumps for temporary ventricular support. 2015. Available: https:\/\/www.federalregister.gov\/documents\/2015\/06\/08\/2015-13889\/cardiovascular-devices-reclassification-of-nonroller-type-cardiopulmonary-bypass-blood-pumps-for [Accessed 26 Jan 2023]."},{"key":"2024051514373634000_5.1.e000186.14","unstructured":"U.S. Food and Drug Administration . Medical devices; neurological devices; classification of the Digital therapy device to reduce sleep disturbance for psychiatric conditions. 2023. Available: https:\/\/www.federalregister.gov\/documents\/2023\/01\/13\/2023-00497\/medical-devices-neurological-devices-classification-of-the-digital-therapy-device-to-reduce-sleep [Accessed 26 Jan 2023]."},{"key":"2024051514373634000_5.1.e000186.15","unstructured":"U.S. Food and Drug Administration . Medical devices; gastroenterology-urology devices; classification of the computerized behavioral therapy device for treating symptoms of gastrointestinal conditions. 2023. Available: https:\/\/www.federalregister.gov\/documents\/2023\/01\/20\/2023-01048\/medical-devices-gastroenterology-urology-devices-classification-of-the-computerized-behavioral [Accessed 26 Jan 2023]."},{"key":"2024051514373634000_5.1.e000186.16","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jama.2022.23279","article-title":"Use of recalled devices in new device authorizations under the US Food and Drug Administration\u2019s 510(K) pathway and risk of subsequent recalls","volume":"329","author":"Kadakia","year":"2023","journal-title":"JAMA"},{"key":"2024051514373634000_5.1.e000186.17","unstructured":"U.S. Food and Drug Adminstration . Medical devices; reclassification of the topical oxygen chamber for extremities. 2011. Available: https:\/\/www.govinfo.gov\/content\/pkg\/FR-2011-04-25\/html\/2011-9899.htm [Accessed 26 Jan 2023]."},{"key":"2024051514373634000_5.1.e000186.18","doi-asserted-by":"publisher","DOI":"10.1111\/1468-0009.12403"},{"key":"2024051514373634000_5.1.e000186.19","unstructured":"U.S. Food and Drug Adminstration . Examples of real-world evidence (RWE) used in medical device regulatory decisions. 2020. Available: https:\/\/www.fda.gov\/media\/146258\/download [Accessed 26 Jan 2023]."},{"key":"2024051514373634000_5.1.e000186.20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.8708"}],"container-title":["BMJ Surgery, Interventions, & Health Technologies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjsit-2023-000186","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T17:55:43Z","timestamp":1715795743000},"score":1,"resource":{"primary":{"URL":"https:\/\/sit.bmj.com\/lookup\/doi\/10.1136\/bmjsit-2023-000186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,9,28]]},"published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.1136\/bmjsit-2023-000186"],"URL":"https:\/\/doi.org\/10.1136\/bmjsit-2023-000186","relation":{},"ISSN":["2631-4940"],"issn-type":[{"value":"2631-4940","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9]]}}}